A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma
A Randomised Pragmatic Trial Of Corticosteroid Optimisation In Severe Asthma Using A Composite Biomarker Algorithm To Adjust Corticosteroid Dose Versus Standard Care
Sponsor: Aerocrine AB
A NA clinical study on Severe Persistent Asthma, this trial is completed. The trial is conducted by Aerocrine AB and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jul 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Apr 2019 — Jul 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aerocrine AB
- Belfast Health and Social Care Trust
- Hoffmann-La Roche
- Medical Research Council
For direct contact, visit the study record on ClinicalTrials.gov .